Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Biologics · For physicians

Combining Shockwave Therapy With PRP for Tendinopathy

Published November 21, 2026

Primary Mechanisms
Dual Mechanical & Biochemical

Pairs acoustic mechanotransduction (ESWT) with concentrated autologous growth factors (PRP).

Typical ESWT Cadence
Serial Weekly Sessions

Extracorporeal shockwave protocols are commonly structured across multiple consecutive weekly visits.

Cost Structure Profile
Fixed Capital + Per-Kit Consumable

Combines low-marginal-cost device sessions with single-use autologous centrifugation kits.

Combining shockwave therapy with PRP injections for chronic tendinopathy pairs mechanical stimulation with autologous biochemical signaling to address degenerated, hypovascular tendon tissue. In clinical practice, providers use extracorporeal shockwave therapy (ESWT) to induce neovascularization and cellular mechanotransduction while delivering concentrated platelets to supply localized growth factors at the lesion site. This multimodal approach is frequently evaluated for recalcitrant cases that have failed isolated eccentric loading or single-modality conservative care.

The Pathophysiological Challenge of Chronic Tendinopathy

Chronic tendinopathy is primarily a degenerative condition (tendinosis) rather than an acute inflammatory process. Histologically, affected tendons exhibit disorganized collagen fibers, mucoid degeneration, tenocyte rounding, and poor vascularity, alongside an absence of classic inflammatory cell infiltration. Because the intrinsic healing cascade has stalled, treatments that merely suppress inflammation—such as repeated corticosteroid injections—often provide only transient relief while risking further structural weakening.

For sports medicine physicians and orthopedic specialists, the clinical objective is to re-initiate an orderly reparative response within a chronically hypoxic and hypocellular matrix. Achieving this requires both a metabolic stimulus to wake dormant tenocytes and an adequate supply of trophic factors to support Type I collagen synthesis.

Mechanistic Synergy: Acoustic Energy Meets Autologous Biologics

When evaluating multimodal protocols, clinicians look for complementary mechanisms of action rather than redundant ones. Combining regenerative devices like extracorporeal shockwave systems with autologous biologics targets two distinct phases of tissue remodeling.

Extracorporeal Shockwave Therapy (ESWT)

ESWT delivers high-energy acoustic waves across the skin into the pathological tendon junction. Through the physical process of cavitation and direct mechanical stress, shockwave therapy triggers mechanotransduction. This physical cue stimulates the local release of endogenous angiogenic factors—including vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS)—promoting neovascularization at the bone-tendon junction. Additionally, ESWT modulates pain signaling via hyperstimulation analgesia and reduction of Substance P in the target region.

Platelet-Rich Plasma (PRP)

PRP provides a supraphysiological concentration of autologous platelets suspended in a small volume of plasma. Upon activation by exposed collagen or exogenous activators, alpha granules degranulate to release platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), insulin-like growth factor (IGF-1), and epidermal growth factor (EGF). These signaling proteins recruit circulating mesenchymal progenitor cells, stimulate tenocyte proliferation, and direct extracellular matrix deposition.

Why Combine Them?

In a densely fibrotic or calcific tendon, injecting PRP alone may encounter a poorly vascularized tissue bed with minimal cellular responsiveness. Conversely, applying ESWT alone relies entirely on the patient's baseline local biological reserves to execute the repair initiated by acoustic microtrauma. By pairing the two, ESWT prepares the tissue microenvironment—increasing vascular permeability and upregulating cellular receptors—while PRP supplies the concentrated biochemical payload necessary for matrix remodeling.

Clinical Comparison: Monotherapy vs. Combined Modality

When structuring treatment tiers for orthopedic and musculoskeletal practices, clinicians typically weigh the distinct attributes of each approach:

  • ESWT Monotherapy:
  • Invasiveness: Non-invasive; no skin puncture or blood draw required.
  • Primary Mechanism: Mechanotransduction, neovascularization, calcific deposit disruption, and nociceptive modulation.
  • Clinical Cadence: Typically delivered as a series of weekly sessions over three to five weeks.
  • Ideal Clinical Fit: Early-to-mid-stage tendinopathy, calcific tendinitis, or patients averse to needle-based procedures.
  • PRP Monotherapy:
  • Invasiveness: Minimally invasive; requires venipuncture, centrifugation, and ultrasound-guided intratendinous or peritendinous injection.
  • Primary Mechanism: Direct delivery of concentrated autologous growth factors and cytokines to drive cellular proliferation.
  • Clinical Cadence: Often administered as a single injection or a short series spaced several weeks apart.
  • Ideal Clinical Fit: Partial intrasubstance tears, focal tendinosis on diagnostic ultrasound, and cases unresponsive to physical therapy.
  • Combined ESWT + PRP Protocol:
  • Invasiveness: Minimally invasive component paired with non-invasive serial acoustic therapy.
  • Primary Mechanism: Dual mechanical and biochemical stimulation; acoustic pre-conditioning or post-injection remodeling support.
  • Clinical Cadence: Sequenced over several weeks, coordinating the biological window of platelet degranulation with serial shockwave sessions.
  • Ideal Clinical Fit: Recalcitrant chronic tendinopathies (e.g., Achilles, patellar, lateral epicondylitis, plantar fasciopathy, rotator cuff) that have plateaued with single-modality care.

Sequencing Considerations in Clinical Practice

There is no single universal protocol for sequencing ESWT and PRP; clinical approaches generally fall into three frameworks based on the treating physician's rationale and the specific pathology:

  1. ESWT Pre-Conditioning Followed by PRP: The clinician administers one to three sessions of shockwave therapy prior to the PRP injection. The rationale is to break up fibrotic tissue, stimulate early angiogenesis, and upregulate local cellular activity so the tissue bed is primed when the autologous concentrate is introduced.
  2. PRP Injection Followed by Delayed ESWT: The clinician performs the ultrasound-guided PRP injection first, allows the acute inflammatory and proliferative cascade to progress undisturbed for two to four weeks, and then introduces ESWT to stimulate ongoing collagen alignment and maturation.
  3. Concurrent or Same-Visit Application: Some protocols apply shockwave therapy immediately prior to or following the PRP injection during the same clinical encounter to leverage immediate local hyperemia or assist in fluid dispersion, though many clinicians prefer separating the modalities to avoid disrupting freshly formed fibrin scaffolds.

Regardless of sequencing, both modalities require integration with a structured, progressive tendon-loading rehabilitation program (such as eccentric or heavy slow resistance exercises) and temporary avoidance of non-steroidal anti-inflammatory drugs (NSAIDs) that could blunt platelet function.

Operational Workflow and Economics for Practice Managers

For practice administrators evaluating the addition of combined regenerative protocols, operational efficiency and cost-per-treatment tracking are critical.

Staffing and Room Utilization

A combined protocol allows practices to balance physician time with clinical support staff utilization. While the PRP preparation requires a trained phlebotomist or medical assistant and the guided injection requires the physician or mid-level provider, serial ESWT sessions can often be delegated to appropriately trained clinical staff (subject to state scope-of-practice regulations). This keeps the physician's schedule open for diagnostic consults and invasive procedures while generating recurring clinical visits in dedicated treatment rooms.

Procurement and Cost Structure

Managing margins on multimodal packages requires attention to both capital equipment and consumable supply chains:

  • Capital vs. Consumable Costs: ESWT represents a fixed capital acquisition with minimal per-treatment consumable costs (primarily acoustic coupling gel and periodic handpiece maintenance/revision kits). PRP represents a variable per-procedure cost driven by specialized centrifugation kits, anticoagulants, blood draw supplies, and ultrasound probe covers.
  • Bundled Care Packages: Because chronic tendinopathy treatments are frequently self-pay or cash-pay services, combining ESWT and PRP into a structured longitudinal care package provides clear financial transparency for the patient while improving treatment adherence across the full remodeling timeline.
  • Supply Chain Standardization: Sourcing both reliable centrifugation hardware/kits and acoustic wave technologies through a single vetted distributor simplifies staff training, warranty management, and inventory par levels.

What This Means for Your Practice

If you are considering integrating or formalizing a combined ESWT and PRP protocol for chronic tendinopathy, take the following steps to ensure clinical and operational readiness:

  • Audit Your Diagnostic Workflow: Ensure point-of-care musculoskeletal ultrasound is integrated into your intake process to accurately differentiate partial macro-tears from diffuse tendinosis, guiding whether monotherapy or combination therapy is warranted.
  • Standardize Your PRP Preparation: Evaluate your current PRP systems to verify whether you are producing leukocyte-rich (LR-PRP) or leukocyte-poor (LP-PRP) concentrates, and align your preparation protocol with the specific tendon pathology being treated.
  • Evaluate Your Shockwave Technology: Determine whether your clinical volume and target pathologies call for radial pressure wave (RPW) devices, focused shockwave (fESWT) systems, or a dual-modality platform.
  • Map the Patient Journey: Build clear post-procedure instructions that outline NSAID washout periods, activity restrictions between PRP and ESWT sessions, and physical therapy milestones.

To evaluate specific PRP systems, biologic consumables, and shockwave platforms tailored to your musculoskeletal service line, contact our team for a clinical and operational consultation.

Frequently asked questions

Why combine shockwave therapy with PRP instead of using either treatment alone?
Chronic tendinopathy involves both poor vascularity and a stalled cellular repair response. Shockwave therapy uses acoustic energy to trigger mechanotransduction and neovascularization, while PRP supplies concentrated autologous growth factors directly to the lesion. Combining them addresses both the physical tissue microenvironment and the biological signaling required for tendon remodeling.
Should shockwave therapy be performed before or after a PRP injection?
Clinical protocols vary based on the treating physician's objective. Some clinicians perform ESWT for one to three sessions prior to PRP to pre-condition the tissue and increase local vascularity, while others administer the PRP injection first and introduce ESWT two to four weeks later to support collagen maturation during the remodeling phase.
What types of chronic tendinopathy are commonly evaluated for combined ESWT and PRP?
Physicians most frequently evaluate combined protocols for recalcitrant tendinopathies that have failed conservative physical therapy. Common anatomical targets include the Achilles tendon, patellar tendon, lateral epicondyle (tennis elbow), plantar fascia, and rotator cuff tendons.
What is the difference between focused shockwave and radial pressure wave therapy in tendon care?
Focused shockwave therapy concentrates acoustic energy at a specific, adjustable depth within the tissue, making it suited for deeper structures, insertional calcifications, and precise lesion targeting. Radial pressure wave therapy disperses energy more superficially across a broader area, which is often utilized for superficial tendons and surrounding myofascial chains.
How does combining ESWT and PRP impact practice workflow and staffing?
Combining these modalities allows practices to optimize provider time across a multi-week care plan. The physician performs the initial diagnostic ultrasound and guided PRP injection, while trained clinical staff (where permitted by state regulations) can administer the serial follow-up ESWT sessions and coordinate rehabilitation milestones.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →